Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer
- PMID: 14559848
Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer
Abstract
Cancer-derived matrix metalloproteinases (MMPs) are proposed to be essential for tumor stromal invasion and subsequent metastasis. To explore the role of MMPs in cancer progression, we examined the expression of various MMPs and tissue inhibitors of MMPs in precancerous and cancerous lesions of the uterine cervix. Immunohistochemical studies demonstrated that MMP-2 and MMP-9 were expressed in >90% of squamous cell carcinomas (SCC) and 83-100% of high-grade squamous intraepithelial lesions (HSIL), but were less frequently expressed in low-grade squamous intraepithelial lesions and normal squamous epithelium (13%). MMP-1, MMP-14, and MMP-15 were detected in 55-81% of SCC cases, and MMP-1 was detected in 39% of HSIL. The tissue inhibitors of MMPs were weakly expressed in SCC (10-61%). By direct analysis of enzyme activities in microdissected specimens, we found that the gelatinolytic activity of MMP-9 was significantly higher in HSIL and SCC than in normal cervix (P < 0.01). The levels of active-form MMP-2 increased progressively from HSIL to SCC of stage I and more advanced stages (P < 0.01). The gelatinolytic activity of MMP-9 and active-form MMP-2 in SCC were strongly correlated with lymphovascular permeation and subsequent lymph node metastasis (P < 0.02). Moreover, the gelatinolytic activity and immunoreactive percentage of both MMP-2 and MMP-9 were significantly higher in SCC cases who had a recurrence than in those who remained free of disease (P < 0.001). Thus, our data demonstrate progressively up-regulated expression of MMP-2 and MMP-9 with SCC progression, and significant associations among their gelatinolytic activity and stage, nodal metastasis, and recurrence.
Similar articles
-
Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.Gynecol Oncol. 1999 Mar;72(3):380-6. doi: 10.1006/gyno.1998.5285. Gynecol Oncol. 1999. PMID: 10053110
-
Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion.Cancer Res. 2005 Aug 1;65(15):6543-50. doi: 10.1158/0008-5472.CAN-05-0231. Cancer Res. 2005. PMID: 16061633
-
Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervix.J Cancer Res Clin Oncol. 2003 Feb;129(2):123-31. doi: 10.1007/s00432-002-0411-9. Epub 2003 Feb 19. J Cancer Res Clin Oncol. 2003. PMID: 12669237
-
[Matrix metalloproteinases and their endogenous regulators in squamous cervical carcinoma (review of the own data)].Biomed Khim. 2015 Nov-Dec;61(6):694-704. doi: 10.18097/PBMC20156106694. Biomed Khim. 2015. PMID: 26716740 Review. Russian.
-
Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer.Exp Dermatol. 2003 Apr;12(2):109-25. doi: 10.1034/j.1600-0625.2003.120201.x. Exp Dermatol. 2003. PMID: 12702139 Review.
Cited by
-
PARP-1 depletion in combination with carbon ion exposure significantly reduces MMPs activity and overall increases TIMPs expression in cultured HeLa cells.Radiat Oncol. 2016 Sep 22;11(1):126. doi: 10.1186/s13014-016-0703-x. Radiat Oncol. 2016. PMID: 27659937 Free PMC article.
-
Systematic analysis to identify a key role of CDK1 in mediating gene interaction networks in cervical cancer development.Ir J Med Sci. 2016 Feb;185(1):231-9. doi: 10.1007/s11845-015-1283-8. Epub 2015 Mar 19. Ir J Med Sci. 2016. PMID: 25786624
-
Study of the Relationship between MMP-2 and MMP-9 and Her2/neu Overexpression in Gastric Cancer: Clinico- Pathological Correlations.Asian Pac J Cancer Prev. 2021 Mar 1;22(3):811-817. doi: 10.31557/APJCP.2021.22.3.811. Asian Pac J Cancer Prev. 2021. PMID: 33773545 Free PMC article.
-
A Study of Matrix Metalloproteinase-2 and Interleukin-18 in Preinvasive and Invasive Lesions of Cancer Cervix.J Midlife Health. 2020 Oct-Dec;11(4):236-239. doi: 10.4103/jmh.JMH_87_19. Epub 2021 Jan 21. J Midlife Health. 2020. PMID: 33767565 Free PMC article.
-
Systematic approach to identify therapeutic targets and functional pathways for the cervical cancer.J Genet Eng Biotechnol. 2023 Feb 1;21(1):10. doi: 10.1186/s43141-023-00469-x. J Genet Eng Biotechnol. 2023. PMID: 36723760 Free PMC article.